Mar 1 2010
Merck, the global pharmaceutical and chemical company, announced it is to acquire all outstanding shares of Millipore, the US life sciences company, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately EUR 5.3 billion (US$ 7.2 billion), creating a world-class partner for the life science sector.
In a video interview on broadcaster http://www.cantos.com, Dr Karl-Ludwig Klay, Merck Chief Executive, said the transaction was "truly transformational" for Merck's Chemicals business.
"We believe that the acquisition is very compelling and fully in line with our strategy."